These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31822518)

  • 1. Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction.
    Fan Q; He W; Gayen M; Benoit MR; Luo X; Hu X; Yan R
    J Neurosci; 2020 Jan; 40(5):1133-1144. PubMed ID: 31822518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer's amyloid pathology.
    Fan Q; Gayen M; Singh N; Gao F; He W; Hu X; Tsai LH; Yan R
    J Exp Med; 2019 Aug; 216(8):1891-1903. PubMed ID: 31209068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically enhancing the expression of chemokine domain of CX
    Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K
    J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
    Ghosal K; Fan Q; Dawson HN; Pimplikar SW
    PLoS One; 2016; 11(7):e0159435. PubMed ID: 27459671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
    Lee HG; Ueda M; Zhu X; Perry G; Smith MA
    J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.
    Nash KR; Lee DC; Hunt JB; Morganti JM; Selenica ML; Moran P; Reid P; Brownlow M; Guang-Yu Yang C; Savalia M; Gemma C; Bickford PC; Gordon MN; Morgan D
    Neurobiol Aging; 2013 Jun; 34(6):1540-8. PubMed ID: 23332170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease.
    Li A; Zhao J; Fan C; Zhu L; Huang C; Li Q; Gan D; Wen C; Chen M; Lu D
    Neurobiol Aging; 2020 Feb; 86():81-91. PubMed ID: 31837910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
    Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
    FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.
    Demars M; Hu YS; Gadadhar A; Lazarov O
    J Neurosci Res; 2010 Aug; 88(10):2103-17. PubMed ID: 20209626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice.
    Winter AN; Subbarayan MS; Grimmig B; Weesner JA; Moss L; Peters M; Weeber E; Nash K; Bickford PC
    J Neuroinflammation; 2020 May; 17(1):157. PubMed ID: 32410624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
    Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
    J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
    J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.